These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9741396)

  • 1. Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats.
    Ogata A; Nagashima K; Yasui K; Matsuura T; Tashiro K
    J Neurol Sci; 1998 Aug; 159(2):135-9. PubMed ID: 9741396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
    Ogata A; Hamaue N; Terado M; Minami M; Nagashima K; Tashiro K
    J Neurol Sci; 2003 Jan; 206(1):79-83. PubMed ID: 12480089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thyrotropin-releasing hormone on pentobarbitone-induced sleep in rats: continuous treatment with a sustained release injectable formulation.
    Hashimoto T; Wada T; Fukuda N; Nagaoka A
    J Pharm Pharmacol; 1993 Feb; 45(2):94-7. PubMed ID: 8095539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thyrotrophin-releasing hormone tartrate and its sustained release formulation on cerebral glucose metabolism in aged rats.
    Nakayama T; Nagai Y
    J Pharm Pharmacol; 1997 Sep; 49(9):884-91. PubMed ID: 9306256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of thyrotropin releasing hormone from microspheres: evaluation of release profiles and pharmacokinetics after subcutaneous administration.
    Heya T; Mikura Y; Nagai A; Miura Y; Futo T; Tomida Y; Shimizu H; Toguchi H
    J Pharm Sci; 1994 Jun; 83(6):798-801. PubMed ID: 9120809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
    Hamaue N; Minami M; Terado M; Hirafuji M; Endo T; Machida M; Hiroshige T; Ogata A; Tashiro K; Saito H; Parvez SH
    Neurotoxicology; 2004 Jan; 25(1-2):205-13. PubMed ID: 14697895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rat model of Parkinson's disease induced by Japanese encephalitis virus.
    Ogata A; Tashiro K; Nukuzuma S; Nagashima K; Hall WW
    J Neurovirol; 1997 Apr; 3(2):141-7. PubMed ID: 9111176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice.
    Miyamoto M; Hirai K; Heya T; Nagaoka A
    Eur J Pharmacol; 1994 Dec; 271(2-3):357-66. PubMed ID: 7705436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of thyrotropin and prolactin responsiveness to thyrotropin releasing hormone stimulation in L-dopa treated parkinsonian patients.
    Rabey JM; Vardi Y; Ravid R; Ayalon D
    Horm Res; 1981; 15(2):78-87. PubMed ID: 6799381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers.
    Takada S; Uda Y; Toguchi H; Ogawa Y
    PDA J Pharm Sci Technol; 1995; 49(4):180-4. PubMed ID: 7552237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
    Narumi S; Nagawa Y
    Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways.
    Engler D; Chad D; Jackson IM
    J Clin Invest; 1982 Jun; 69(6):1310-20. PubMed ID: 6806317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
    Minami M; Hamaue N; Hirafuji M; Saito H; Hiroshige T; Ogata A; Tashiro K; Parvez SH
    J Neural Transm Suppl; 2006; 71(71):87-95. PubMed ID: 17447419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lactic/glycolic acid) microspheres.
    Heya T; Okada H; Ogawa Y; Toguchi H
    J Pharm Sci; 1994 May; 83(5):636-40. PubMed ID: 8071811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain catecholamine alterations and pathological features with aging in Parkinson disease model rat induced by Japanese encephalitis virus.
    Hamaue N; Ogata A; Terado M; Ohno K; Kikuchi S; Sasaki H; Tashiro K; Hirafuji M; Minami M
    Neurochem Res; 2006 Dec; 31(12):1451-5. PubMed ID: 17103330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
    Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
    Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin-releasing hormone (TRH) content of rat striatum: modification by drugs and lesions.
    Spindel ER; Pettibone DJ; Wurtman RJ
    Brain Res; 1981 Jul; 216(2):323-31. PubMed ID: 6265032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vagotomy on hyperactivity and increased dopamine turnover induced by intraperitoneal administration of thyrotropin-releasing hormone.
    Ogawa N; Asanuma M; Kondo Y; Hirata H; Nakayama N; Mori A
    Brain Res; 1994 Jan; 633(1-2):167-70. PubMed ID: 8137153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRH Analog, Taltirelin Improves Motor Function of Hemi-PD Rats Without Inducing Dyskinesia via Sustained Dopamine Stimulating Effect.
    Zheng C; Chen G; Tan Y; Zeng W; Peng Q; Wang J; Cheng C; Yang X; Nie S; Xu Y; Zhang Z; Papa SM; Ye K; Cao X
    Front Cell Neurosci; 2018; 12():417. PubMed ID: 30555300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.